ㄴㄴ
J Neurosonol Neuroimag Search

CLOSE


J Neurosonol Neuroimag > Volume 17(2); 2025 > Article
Choi and Han: Marchiafava–Bignami disease
A 48-year-old woman with a history of chronic alcohol use and alcoholic liver cirrhosis presented with a 6‑month history of dizziness and gait disturbances that had acutely worsened over 5 days. She reported non-spinning dizziness and a unilateral tendency to fall while walking. The medical history included esophageal variceal bleeding, which was treated with endoscopic ligation, poor nutritional intake, and poor treatment compliance. On examination, she was alert but showed an unsteady gait and truncal instability without limb weakness. Routine laboratory tests revealed chronic liver disease without major metabolic derangement. Brain diffusion-weighted imaging revealed symmetric high-signal lesions in the splenium of the corpus callosum, bilateral peritrigonal white matter, periphery of the cerebral peduncle, corona radiata, and centrum semiovale, and this was compatible with Marchiafava–Bignami disease (MBD) in the clinical context of chronic alcoholism and malnutrition (Fig. 1A).1-3 High‑dose parenteral thiamine and multivitamin supplementation were started immediately. Dizziness and gait disturbance gradually improved over subsequent days. After clinical stabilization and partial neurological recovery, the patient was discharged on oral thiamine, nutritional support, and strict alcohol-cessation counseling.
MBD is a rare metabolic encephalopathy wherein the corpus callosum undergoes inflammatory damage, demyelination, and eventual tissue loss, which most commonly affects individuals with chronic alcoholism and malnutrition.1,3 Pathologically, cytotoxic edema and blood–brain barrier disruption advances to callosal demyelination and atrophy, particularly in the genu and splenium.2,3 Clinically, patients present with a wide spectrum of symptoms—from gait disturbance, dysarthria, and cognitive or behavioral changes to coma and seizures, which frequently overlap with other alcohol‑related encephalopathies.4 The diagnosis relies on MRI, which typically reveals hyperintense callosal lesions on T2‑weighted and fluid-attenuated inversion recovery sequence, and this is often with spread into the nearby supratentorial white matter (Fig. 1B, 1C).1 In the absence of standardized treatment, high-dose parenteral thiamine, vitamin supplementation, and alcohol cessation are associated with improved prognosis.2,3

NOTES

Ethics Statement
This study was approved by the Clinical Trial Review Committee of Inje University Sanggye Paik Hospital (Approval No. SGPAIK 2025-04-012). The requirement for informed consent was waived as the database was only accessed for analytical purposes.
Availability of Data and Material
All data related to this study are included in the main text.
Author Contributions
Conceptualization: SWH. Resources and Supervision: SWH. Visualization and Writing–original draft: HJC. Writing– review editing: HJC, SWH.
Acknowledgments
None.
Sources of Funding
None.
Conflicts of Interest
No potential conflicts of interest relevant to this article was reported.

Fig. 1.
Brain magnetic resonance imaging. (A) Diffusion-weighted images demonstrating nearly symmetric high-signal lesions involving the splenium of the corpus callosum, bilateral peritrigonal white matter, periphery of the cerebral peduncles, corona radiata, and centrum semiovale; these findings are consistent with Marchiafava–Bignami disease. Diffusion-restricted lesions correspond to T1‑weighted hypointensity (B) and fluid-attenuated inversion recovery hyperintensity (C).
jnn-2025-00177f1.jpg

REFERENCES

1. Kuroda T, Kawamura M. Diagnostic imaging of marchiafava-bignami disease. Brain Nerve. 2014;66:1079-1088.
pmid
2. Parmanand HT. Marchiafava-Bignami disease in chronic alcoholic patient. Radiol Case Rep. 2016;11:234-237.
crossref pmid pmc
3. Tian TY, Pescador Ruschel MA, Park S, Liang JW. Marchiafava-Bignami disease. In: StatPearls. StatPearls Publishing. 2023.

4. Liu C, Wang H, Xie B, Tian S, Ding Y. Clinical analysis of Marchiafava-Bignami disease. BMC Neurol. 2024;24:389.
crossref pmid pmc pdf
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 1,367 View
  • 19 Download
Related articles in AC


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
1412, 359, Gangnam-daero, Seocho-gu, Seoul, Republic of Korea
E-mail: ksn@neurosonology.or.kr                

Copyright © 2026 by Korean Society of Neurosonology.

Developed in M2PI

Close layer
prev next